Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INDINAVIR for Chronic hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where INDINAVIR was used for Chronic hepatitis c.

Most Reported Side Effects for INDINAVIR

Side Effect Reports % Deaths Hosp.
Lipodystrophy acquired 195 26.8% 0 19
Eyelid ptosis 158 21.7% 0 0
Mitochondrial toxicity 156 21.4% 0 0
Diplopia 155 21.3% 0 0
Virologic failure 100 13.7% 3 19
Drug resistance 93 12.8% 4 9
Viral mutation identified 93 12.8% 0 2
Pathogen resistance 85 11.7% 0 16
Dysphagia 82 11.3% 0 0
Foetal exposure during pregnancy 76 10.4% 2 29
Progressive external ophthalmoplegia 74 10.2% 0 0
Ophthalmoplegia 58 8.0% 0 0
Blood lactic acid increased 54 7.4% 0 12
Treatment failure 42 5.8% 0 0
Drug ineffective 40 5.5% 1 6

Other Indications for INDINAVIR

Hiv infection (536) Product used for unknown indication (67) Antiretroviral therapy (44) Acquired immunodeficiency syndrome (11)

Other Drugs Used for Chronic hepatitis c

RIBAVIRIN (15,707) PEGINTERFERON ALFA-2A (7,898) LEDIPASVIR\SOFOSBUVIR (6,621) SOFOSBUVIR\VELPATASVIR (6,405) SOFOSBUVIR (6,008) TELAPREVIR (3,103) GLECAPREVIR\PIBRENTASVIR (3,072) SIMEPREVIR (2,735) DACLATASVIR (2,063) PEGINTERFERON ALFA-2B (1,927)

Related Pages

INDINAVIR Full Profile All Chronic hepatitis c Drugs INDINAVIR Demographics INDINAVIR Timeline